Skip to main content
SpringerLink
Log in

Health Care Policy and Regulation

  • Book
  • © 1995

Overview

Editors:
  1. Thomas A. Abbott

    1. Graduate School of Management, Rutgers University, Newark, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Topics in Regulatory Economics and Policy (TREP, volume 20)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Introduction

    1. Health Care Policy and Regulation: Introduction

      • Thomas A. Abbott III
      Pages 1-9

  3. Health Care Reform

    1. Front Matter

      Pages 11-11
      Download chapter PDF

    2. Lessons from Public Utility Regulation for the Economic Regulation of Health Care Markets: An Overview

      • Thomas A. Abbott III, Michael A. Crew
      Pages 13-43

    3. Regulatory Strategies Under Managed Competition Health Care Reforms

      • Mark Schlesinger
      Pages 45-79

    4. Health Care Cost Containment in Connecticut

      • L. Spencer Cain
      Pages 81-91

    5. Health Care Reform in New Jersey

      • Pamela S. Dickson
      Pages 93-95

    6. Health Security Act: Summary and Impact

      • Ronald Rouse, Philip Vernon, Linda Stackman, Keith Servis
      Pages 97-101

  4. Price Regulation

    1. Front Matter

      Pages 103-103
      Download chapter PDF

    2. Regulating Pharmaceutical Prices

      • Thomas A. Abbott III
      Pages 105-141

    3. Hospital Price Regulation: Evidence and Implications for Health Care Reform

      • Jack Hadley
      Pages 143-162

    4. Paying Physicians as Agents: Fee-For-Service, Caption, or Hybrids?

      • Mark V. Pauly
      Pages 163-180

  5. Quality Regulation

    1. Front Matter

      Pages 181-181
      Download chapter PDF

    2. Medical Practice Guidelines and the Efficient Allocation of Resources

      • John A. Rizzo, Jody L. Sindelar
      Pages 183-203

    3. Contending Views of Quality Management in Health Care: Implications for Competition and Regulation

      • David Blumenthal, Richard Bohmer
      Pages 205-229

    4. Measuring and Improving Quality in Health Care

      • Mark R. Chassin
      Pages 231-242

  6. Back Matter

    Pages 243-261
    Download chapter PDF
Back to top

Keywords

About this book

5 care reforms. Part II: Price Regulation The second partofthis volume examines the role ofprice regulation in controlling health care costs. It contains three chapters. In chapter seven, I examine the alternatives for regulating pharmaceutical prices. In chapter eight, Jack Hadley examines the impactofvarious forms ofhospital price regulation; while in chapter nine,MarkPaulyexaminestheroleofpriceregulation incontrollingphysician fees. Chapter seven focuses on the issue of regulating pharmaceutical prices. There are two key issues examined in this paper. First, is there a clear need for price regulation, and second, can price regulation work in this industry? In response to the first question, I come to the conclusion that the proponents ofprice regulation have not really proven their case. Although the financial returns in the pharmaceu­ tical industry have been slightly higher than expected during the 1970s and 1980s, there is not overwhelming evidence of"price gouging" or excessive profits on the part of the industry. In response to the second question, the answer is clearly no. The traditional approaches to price regulation will not have the intended affect of eliminating excess profits from the industry while maintaining the incentives for research and development. First, rate-of-return regulation, the most natural approach, would result in many adverse incentives-includingexcessive investment in research and developmentinorderto inflatetheratebaseused tocalculatedtheallowablereturns.

Editors and Affiliations

  • Graduate School of Management, Rutgers University, Newark, USA

    Thomas A. Abbott

Bibliographic Information

  • Book Title: Health Care Policy and Regulation

  • Editors: Thomas A. Abbott

  • Series Title: Topics in Regulatory Economics and Policy

  • DOI: https://doi.org/10.1007/978-1-4615-2219-5

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1995

  • Hardcover ISBN: 978-0-7923-9540-9Published: 28 February 1995

  • Softcover ISBN: 978-1-4613-5932-6Published: 27 September 2012

  • eBook ISBN: 978-1-4615-2219-5Published: 06 December 2012

  • Series ISSN: 2730-7468

  • Series E-ISSN: 2730-7476

  • Edition Number: 1

  • Number of Pages: X, 261

  • Topics: Industrial Organization, Economic Policy, Public Health

Publish with us

Policies and ethics

Back to top

Search

Navigation